Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
29.46
-0.18 (-0.61%)
At close: Jun 5, 2026, 4:00 PM EDT
29.35
-0.11 (-0.37%)
After-hours: Jun 5, 2026, 6:49 PM EDT
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $95.9 million as of June 5, 2026. Its market cap has increased by 111.71% in one year.
Market Cap
95.90M
Enterprise Value
81.90M
1-Year Change
111.71%
Ranking
Category
Stock Price
$29.46
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $95.90M, a decrease of -50.44%. That is a compound annual growth rate of -7.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 119.20M | 396.67% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PepGen | 102.37M |
| Oncolytics Biotech | 100.68M |
| Biomea Fusion | 99.05M |
| Outlook Therapeutics | 96.06M |
| Inovio Pharmaceuticals | 95.05M |
| Rein Therapeutics | 94.90M |
| PolyPid | 92.61M |
| Fortress Biotech | 92.02M |